HealthTech
Convergence in the blood: How AI and biotech are rewriting cancer detection across Asia
Industrial bases, not just science, will determine whether breakthroughs become real benefits.
Singapore’s Brano Therapeutics raises $6.8M seed funding to advance heart failure treatments
Brano Therapeutics, a spin-off from Singapore's Duke-NUS Medical School, has secured $6.8 million in seed funding to support the development of new treatments for heart failure, including heart failure with preserved ejection fraction (HFpEF), a condition with limited therapeutic options.
Singapore healthcare firm UltraGreen.ai secures approval for Verdye surgery
UltraGreen.ai Limited (SGX: ULG) has received regulatory approval in Singapore for Verdye, an indocyanine green (ICG) injection used in fluorescence-guided surgery.
Ekuinas acquires strategic minority stake in Malaysia’s pharmaceutical firm Ain Medicare
Ekuiti Nasional Berhad (Ekuinas) announced Tuesday its investment in Ain Medicare Sdn Bhd, a Bumiputera home-grown manufacturer of sterile parenteral pharmaceutical products.
Singapore healthtech startup injewelme raises $1.2m to advance AI monitoring technology
Catalytic Capital for Climate and Health (C3H), a catalytic investment vehicle of Temasek Trust, has led a US$1.2 million funding round in Singapore-based AI healthtech startup injewelme, C3H said in a press release on Wednesday.
Singapore’s private healthcare fragmentation spurs rise of integrated, tech-driven platforms [interview]
As digital transformation accelerates across industries, Singapore’s private healthcare sector is facing a critical bottleneck: while medical innovation and digital tools are advancing rapidly, the underlying infrastructure connecting providers, insurers, and patients remains fragmented.
SeaX Ventures invests $10M in RyboDyn’s AI-driven cancer research
SeaX Ventures will continue investing in RyboDyn, a biotechnology startup based in the United States, as part of the latter's $10 million seed funding round.
Singapore’s UltraGreen.ai delivers 24 percent revenue growth in FY2025 to $142.4M
UltraGreen.ai Limited, the Singapore-based fluorescence-guided surgery and digital health solutions provider backed by Temasek entity 65 Equity Partners, has delivered 24 percent revenue growth in the financial year ended December 31, 2025 (FY2025) to $142.4 million.
Gobi Partners invests in Malaysia-based AI healthcare firm Valiance Health
Gobi Partners, through its SuperSeed II Fund, has led an undisclosed pre-seed investment in Valiance Health Inc., a Malaysia-based artificial intelligence (AI) healthcare company building the country’s first large-scale standardized healthcare data platform.
Why AI needs a doctor’s hand to build reliable healthcare technology
The next generation of #AI in #healthcare will not be defined by faster models or bigger datasets, but by the trust they can earn.
